Skip to main content
. Author manuscript; available in PMC: 2024 Oct 28.
Published in final edited form as: J Rheumatol. 2020 May 1;48(2):293–298. doi: 10.3899/jrheum.191242

Table 5.

Hypothetical maximal flare occurrence for each disease state.

Time Horizon Disease State No. Flares, Median (IQR) P *

No. flares over 6 months Remission 0 (0–0) < 0.001
LDA 1 (0–2)
PASS 0 (0–1)
No. flares over 12 months Remission 0 (0–0) < 0.001
LDA 1 (0–2)
PASS 0 (0–2)
*

From related samples Friedman 2-way ANOVA by ranks (all pairwise comparisons were also statistically significant).

LDA: low disease activity; PASS: patient acceptable symptom state.